Yuuwa

Yuuwa is an early-stage venture capital firm founded in 2009 and based in Perth, Australia. The firm focuses on investing in promising biotechnology and software companies primarily within the Asia-Pacific region. With a commitment to supporting founders and early investors, Yuuwa aims to transform innovative ideas into successful businesses by providing both capital and strategic expertise. The firm emphasizes sectors such as life sciences, pharmaceuticals, and technology, actively seeking outstanding investment opportunities that align with its focus areas.

17 past transactions

Nexgen Plants

Venture Round in 2018
Nexgen Plants is an innovative plant trait company focused on developing non-genetically modified (non-GM) solutions to enhance agricultural productivity and resilience against various challenges. The company specializes in creating disease-resistant plant breeds by leveraging a proprietary transformation technique that identifies key elements in native DNA. This approach enables the development of crops that are resistant to viruses and fungi, as well as traits such as salt tolerance and increased anthocyanin content. Nexgen Plants aims to produce the next generation of globally valued crops for food, fiber, energy, and ornamental purposes, ultimately helping agriculture-dependent communities improve their returns and adapt to emerging opportunities.

iCetana

Series C in 2017
iCetana Limited, established in 2009 and based in Perth, Australia, specializes in video analytics solutions. The company develops and markets iCetana Solution, an AI-assisted software for real-time detection of unusual events in video surveillance networks. Serving diverse industries such as campuses, logistics, manufacturing, and finance, iCetana's software integrates with existing systems and IP cameras, providing automated, real-time anomalous event detection across multiple geographical regions, including Asia Pacific, North America, and Europe, Middle East & Africa.

Agworld

Series C in 2014
Agworld is a farm management software company headquartered in Perth, Australia, with additional offices in Windsor, Colorado, and Sacramento, California. The company operates in Australia, the USA, New Zealand, and South Africa, offering a data capture and management platform that connects various stakeholders in the agricultural industry. Users can collect and share data seamlessly, enabling them to make more informed and profitable decisions. The platform supports farm planning, budgeting, and tracking of product inputs, with all data stored in the cloud for easy access from any computer or smartphone. Agworld's integration with other industry players allows users to import data from multiple sources, facilitating comprehensive analyses and reporting. By leveraging historical records and insights shared from advisors, Agworld empowers farmers and agronomists to enhance their decision-making processes.

Fitgenes

Venture Round in 2014
Fitgenes is an Australian organization that specializes in personalized, genome-based health and wellness programs aimed at optimizing individual health potential. Founded in 2007, the company utilizes DNA testing to uncover genetic predispositions related to fitness, health, and nutrition. By combining genetic profiling with comprehensive health and risk assessments, Fitgenes addresses lifestyle-related health issues such as metabolic and weight management, diabetes, cardiovascular health, chronic inflammation, and bone health. The organization operates corporate offices in Brisbane and Melbourne, with certified practitioners offering services across Australia, New Zealand, Malaysia, Singapore, Hong Kong, and the United States. Through its platform, Fitgenes empowers individuals to make informed dietary and lifestyle choices, ultimately enhancing their overall well-being.

Nexgen Plants

Series A in 2013
Nexgen Plants is an innovative plant trait company focused on developing non-genetically modified (non-GM) solutions to enhance agricultural productivity and resilience against various challenges. The company specializes in creating disease-resistant plant breeds by leveraging a proprietary transformation technique that identifies key elements in native DNA. This approach enables the development of crops that are resistant to viruses and fungi, as well as traits such as salt tolerance and increased anthocyanin content. Nexgen Plants aims to produce the next generation of globally valued crops for food, fiber, energy, and ornamental purposes, ultimately helping agriculture-dependent communities improve their returns and adapt to emerging opportunities.

iCetana

Series B in 2013
iCetana Limited, established in 2009 and based in Perth, Australia, specializes in video analytics solutions. The company develops and markets iCetana Solution, an AI-assisted software for real-time detection of unusual events in video surveillance networks. Serving diverse industries such as campuses, logistics, manufacturing, and finance, iCetana's software integrates with existing systems and IP cameras, providing automated, real-time anomalous event detection across multiple geographical regions, including Asia Pacific, North America, and Europe, Middle East & Africa.

Eridan

Seed Round in 2013
Eridan Technology is a Norway-based company headquartered in Aust-Agder, specializing in innovative technology for radio frequency communication and drug delivery therapies. The company is developing the world's first digital sampling radio capable of operating across 4G, 5G, and future cellular networks. Its unique transceiver architecture generates all sub-6GHz cellular signals at full transmit power, significantly reducing the need for linear power amplifiers. This fully digital approach to wireless signal generation results in energy consumption that is 5-10 times lower than traditional methods while transmitting the same amount of data. Eridan's technology is designed to operate at any cellular frequency, supporting fast data rates and compatibility with various signal types, thus providing energy-efficient solutions that enhance bandwidth and power capabilities for customers.

PolyActiva

Series B in 2013
PolyActiva is a biotechnology company specializing in the development of proprietary drug-polymer conjugate technology aimed at site-specific drug delivery. The company's innovative delivery platform is designed to facilitate the administration of therapeutic doses over extended periods from various medical device components, including ocular implants, intra-articular gel implants, and drug-eluting fibers. By creating biodegradable implants that sustain drug release, PolyActiva enhances patient outcomes and quality of life, particularly for individuals suffering from ophthalmic diseases such as glaucoma. This technology empowers healthcare organizations to provide more effective drug treatments tailored to the needs of patients.

Agworld

Series B in 2012
Agworld is a farm management software company headquartered in Perth, Australia, with additional offices in Windsor, Colorado, and Sacramento, California. The company operates in Australia, the USA, New Zealand, and South Africa, offering a data capture and management platform that connects various stakeholders in the agricultural industry. Users can collect and share data seamlessly, enabling them to make more informed and profitable decisions. The platform supports farm planning, budgeting, and tracking of product inputs, with all data stored in the cloud for easy access from any computer or smartphone. Agworld's integration with other industry players allows users to import data from multiple sources, facilitating comprehensive analyses and reporting. By leveraging historical records and insights shared from advisors, Agworld empowers farmers and agronomists to enhance their decision-making processes.

Filter Squad

Seed Round in 2011
Filter Squad makes the Discovr series of apps: Discovr Music, Discovr Apps, Discovr Movies. Number 1 app in 52 countries including US, Japan, Australia, and across Europe. More than 1.5 million downloads. Featured worldwide by Apple. Listed as one of Billboard 10 Top Music Startups 2011. Winner of Tech23 Greatest Potential Award 2011. Winner of MIDEM Best Consumer Startup 2011. Featured in the Wall Street Journal, Techcrunch, Mashable, Read Write Web, Gizmodo, Lifehacker, Scobleizer, Macworld, Wired Magazine.

GordianTec

Seed Round in 2011
GordianTec Pty Ltd. is an Australian start-up company founded in 2011 and based in Bentley. It specializes in the development of technology applications for diagnostic purposes, particularly in the fields of diabetes and cancer. The company is engaged in validating algorithms for single nucleotide polymorphism (SNP) data identification, which are associated with disease outcomes and population sub-types. Through its innovative approach, GordianTec aims to enhance the ability of healthcare providers to identify genetic variations linked to these diseases. Additionally, the company is in the process of filing patent applications for its diagnostic technologies and is exploring the expansion of its methodologies to address other medical conditions.

Dealised

Series A in 2011
Dealised is a group buying platform that enables media companies to effectively enter and thrive in their markets. It offers a comprehensive suite of features, including a deal platform, payment gateway, and email management system. The platform is designed to facilitate significant deal transactions globally, supporting millions of dollars in deals. Dealised emphasizes long-term partnerships with its clients rather than providing a simple turnkey solution. Currently, the Dealised Partner Network includes six group-buying businesses that benefit from its technical infrastructure, which delivers tens of thousands of vouchers weekly. In addition to technical support, Dealised provides strategic sales and marketing assistance to enhance the performance of its partners in the competitive group buying space.

Oz Sonotek

Seed Round in 2011
Oz Sonotek is an Australian-incorporated developer of innovative medical technologies designed to better manage ultrasound energy during cataract surgery (phaco-emulsification). The company was founded by Dr Nigel Morlet, eye surgeon and researcher, who has successfully designed and commercialized previous ophthalmic devices, and who has published widely in journals such as New England Journal of Medicine. He has engaged an experienced leadership team that have a successful track record. They are experienced in research, development, commercialization, regulatory, IP protection, sales, distribution, and crafting revenue licensing partnerships with major players. Our principal research themes involve design and test of more efficient needle tips for phacoemulsification, which will be followed by next generation ultrasonic hand-pieces and energy management software improvements. The first product will shortly be introduced into global cataract surgery markets, with highly pedigreed partners. The company now has venture capital shareholders, and in 2012, the won a significant, competitive cash innovation grant from the State of Western Australia. We presented our clinical outcomes at major eye care meetings including Meeting of the American Society of Cataract & Refractive Surgery in 2011 and 2012

Filter Squad

Seed Round in 2011
Filter Squad makes the Discovr series of apps: Discovr Music, Discovr Apps, Discovr Movies. Number 1 app in 52 countries including US, Japan, Australia, and across Europe. More than 1.5 million downloads. Featured worldwide by Apple. Listed as one of Billboard 10 Top Music Startups 2011. Winner of Tech23 Greatest Potential Award 2011. Winner of MIDEM Best Consumer Startup 2011. Featured in the Wall Street Journal, Techcrunch, Mashable, Read Write Web, Gizmodo, Lifehacker, Scobleizer, Macworld, Wired Magazine.

AdAlta

Series A in 2011
AdAlta Limited is a clinical-stage biotechnology company based in Bundoora, Australia, specializing in the discovery and development of protein therapeutics. Established in 2006, the company focuses on novel drug candidates derived from shark antibodies, known as i-bodies, to address various disease conditions. Its lead drug candidate, AD-214, is currently undergoing Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. AdAlta has a strong emphasis on targeting non-traditional antibody targets, including complex membrane-spanning proteins, utilizing its proprietary discovery technology to access previously unreachable drug targets. In addition to developing its own therapeutics, AdAlta engages in collaborative and contract research, leveraging its extensive libraries of i-bodies to support partnerships with research organizations, biotech firms, and pharmaceutical companies.

Agworld

Series A in 2010
Agworld is a farm management software company headquartered in Perth, Australia, with additional offices in Windsor, Colorado, and Sacramento, California. The company operates in Australia, the USA, New Zealand, and South Africa, offering a data capture and management platform that connects various stakeholders in the agricultural industry. Users can collect and share data seamlessly, enabling them to make more informed and profitable decisions. The platform supports farm planning, budgeting, and tracking of product inputs, with all data stored in the cloud for easy access from any computer or smartphone. Agworld's integration with other industry players allows users to import data from multiple sources, facilitating comprehensive analyses and reporting. By leveraging historical records and insights shared from advisors, Agworld empowers farmers and agronomists to enhance their decision-making processes.

iCetana

Series A in 2010
iCetana Limited, established in 2009 and based in Perth, Australia, specializes in video analytics solutions. The company develops and markets iCetana Solution, an AI-assisted software for real-time detection of unusual events in video surveillance networks. Serving diverse industries such as campuses, logistics, manufacturing, and finance, iCetana's software integrates with existing systems and IP cameras, providing automated, real-time anomalous event detection across multiple geographical regions, including Asia Pacific, North America, and Europe, Middle East & Africa.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.